Tear Duct OccluderTM is an FDA approved prescription therapeutic device which is intended to temporarily occlude the nasolacrimal ducts in adult patients to help reduce outflow through the nasolacrimal ducts.
The primary users of this device would be glaucoma and dry eye patients. For detail safety and prescribing information, see device patient labeling. Ask your doctor to determine if Tear Duct OccluderTM is right for you.
FDA Regulation Number: 21 CFR 886.5838
U.S. Patent 8147467
Made in U.S.A.